| 1 |
34448823 |
10.1182/bloodadvances.2021004212 |
2022 |
The molecular hallmarks of primary and secondary vitreoretinal lymphoma. |
TBL1XR1 |
| 2 |
34494161 |
10.1007/s00428-021-03186-3 |
2022 |
Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. |
TBL1XR1 |
| 3 |
34791836 |
10.1002/cam4.4422 |
2022 |
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. |
TBL1XR1 |
| 4 |
34799485 |
10.1097/PAS.0000000000001834 |
2022 |
Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation. |
TBL1XR1 |
| 5 |
35205758 |
10.3390/cancers14041010 |
2022 |
Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome. |
TBL1XR1 |
| 6 |
35300216 |
10.2147/JIR.S341355 |
2022 |
The Mutation of <i>BTG2</i> Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma. |
TBL1XR1 |
| 7 |
35401516 |
10.3389/fimmu.2022.842439 |
2022 |
Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma. |
TBL1XR1 |
| 8 |
35583604 |
10.1158/1078-0432.CCR-21-3347 |
2022 |
Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL. |
TBL1XR1 |
| 9 |
35726023 |
10.1038/s41684-022-00998-x |
2022 |
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications. |
TBL1XR1 |
| 10 |
33777766 |
10.3389/fonc.2021.620435 |
2021 |
Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. |
TBL1XR1 |
| 11 |
34147695 |
10.1016/j.jmoldx.2021.04.013 |
2021 |
Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay. |
TBL1XR1 |
| 12 |
35528192 |
10.1158/2767-9764.crc-21-0022 |
2021 |
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways. |
TBL1XR1 |
| 13 |
31557339 |
10.1111/his.14005 |
2020 |
Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing. |
TBL1XR1 |
| 14 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
TBL1XR1 |
| 15 |
32316399 |
10.3390/cancers12040986 |
2020 |
Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing. |
TBL1XR1 |
| 16 |
32322395 |
10.1186/s40364-020-00189-1 |
2020 |
TBL1XR1 mutation predicts poor outcome in primary testicular diffuse large B-cell lymphoma patients. |
TBL1XR1 |
| 17 |
32339039 |
10.1080/02713683.2020.1762228 |
2020 |
<i>TBL1XR1</i> Mutations in Primary Marginal Zone Lymphomas of Ocular Adnexa are Associated with Unique Morphometric Phenotypes. |
TBL1XR1 |
| 18 |
32546039 |
10.1080/10428194.2020.1775216 |
2020 |
TBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell lymphoma. |
TBL1XR1 |
| 19 |
32619424 |
10.1016/j.cell.2020.05.049 |
2020 |
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate. |
TBL1XR1 |
| 20 |
32932517 |
10.1182/blood.2020005857 |
2020 |
The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs. |
TBL1XR1 |
| 21 |
33252851 |
10.1002/ctm2.221 |
2020 |
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. |
TBL1XR1 |
| 22 |
31648321 |
10.1182/bloodadvances.2019000404 |
2019 |
Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. |
TBL1XR1 |
| 23 |
31806993 |
10.2147/OTT.S227122 |
2019 |
Genomic Alterations In Primary Cardiac Diffuse Large B Cell Lymphoma: A Case Report And Literature Review. |
TBL1XR1 |
| 24 |
29674500 |
10.3324/haematol.2018.191601 |
2018 |
Novel <i>GPR34</i> and <i>CCR6</i> mutation and distinct genetic profiles in MALT lymphomas of different sites. |
TBL1XR1 |
| 25 |
29891112 |
10.1016/j.critrevonc.2018.05.010 |
2018 |
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. |
TBL1XR1 |
| 26 |
30214692 |
10.18632/oncotarget.26080 |
2018 |
Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in <i>TNFAIP3</i> followed by mutations in <i>TBL1XR1</i> and <i>CREBBP</i>. |
TBL1XR1 |
| 27 |
30401751 |
10.1182/bloodadvances.2018022962 |
2018 |
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia. |
TBL1XR1 |
| 28 |
28152507 |
10.18632/oncotarget.14928 |
2017 |
The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. |
TBL1XR1 |
| 29 |
28479318 |
10.1016/j.jid.2017.04.010 |
2017 |
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. |
TBL1XR1 |
| 30 |
28509585 |
10.1080/10428194.2017.1318437 |
2017 |
Identification of a novel fusion TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring the DEK-NUP214 fusion and clinical response to dasatinib. |
TBL1XR1 |
| 31 |
26111727 |
10.1111/nan.12259 |
2016 |
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas. |
TBL1XR1 |
| 32 |
26608593 |
10.1002/gcc.22328 |
2016 |
Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma. |
TBL1XR1 |
| 33 |
27248180 |
10.18632/oncotarget.9678 |
2016 |
The genetic landscape of dural marginal zone lymphomas. |
TBL1XR1 |
| 34 |
25991819 |
10.1158/1078-0432.CCR-14-2116 |
2015 |
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. |
TBL1XR1 |
| 35 |
26189108 |
10.1016/j.leukres.2015.06.005 |
2015 |
Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients. |
TBL1XR1 |
| 36 |
23823658 |
10.1038/leu.2013.206 |
2014 |
Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. |
TBL1XR1 |
| 37 |
24689486 |
10.1111/exd.12405 |
2014 |
Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencing. |
TBL1XR1 |
| 38 |
24895125 |
10.1074/jbc.M114.569889 |
2014 |
Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model. |
TBL1XR1 |
| 39 |
24970810 |
10.18632/oncotarget.2080 |
2014 |
Mutational analysis of primary central nervous system lymphoma. |
TBL1XR1 |
| 40 |
22496164 |
10.1182/blood-2012-02-414441 |
2012 |
TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma. |
TBL1XR1 |
| 41 |
22837180 |
10.1158/1078-0432.CCR-12-0845 |
2012 |
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas. |
TBL1XR1 |
| 42 |
23022380 |
10.1016/j.molcel.2012.08.022 |
2012 |
NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. |
TBL1XR1 |
| 43 |
21562036 |
10.1158/1078-0432.CCR-11-0395 |
2011 |
Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens. |
TBL1XR1 |
| 44 |
21680795 |
10.1182/blood-2011-03-341412 |
2011 |
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. |
TBL1XR1 |
| 45 |
20547759 |
10.1128/MCB.01600-09 |
2010 |
The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1. |
TBL1XR1 |
| 46 |
18767146 |
10.1002/gcc.20613 |
2008 |
The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1. |
TBL1XR1 |
Datasets
Models
